Annika Kollén
Director/Board Member at NAVAMEDIC ASA
Profile
Annika Kollén has worked as a Director at Navamedic ASA since 2021 and as EVP-Global Supply Chain & Operations at Inceptua SA since 2018.
Annika Kollén active positions
Companies | Position | Start |
---|---|---|
NAVAMEDIC ASA | Director/Board Member | 2021-06-02 |
Inceptua SA
Inceptua SA Medical/Nursing ServicesHealth Services Inceptua SA is a Luxembourger specialty pharmaceutical company and premium service partner. The company is based in Luxembourg, Luxembourg, and has subsidiaries in the UK. The company commercializes and market orphan and specialty care products, as well as supply unlicensed medicines. Inceptua also provides services such as clinical trial comparator sourcing, packaging and labeling solutions, pre-approval and medicines access programs, and consulting. The company partner with life science companies of all sizes and has over 20 years of industry experience. Inceptua was founded in 1997, and Stefan Fraenkel has been the CEO since 2017. | Chief Operating Officer | 2020-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
NAVAMEDIC ASA | Distribution Services |
Private companies | 1 |
---|---|
Inceptua SA
Inceptua SA Medical/Nursing ServicesHealth Services Inceptua SA is a Luxembourger specialty pharmaceutical company and premium service partner. The company is based in Luxembourg, Luxembourg, and has subsidiaries in the UK. The company commercializes and market orphan and specialty care products, as well as supply unlicensed medicines. Inceptua also provides services such as clinical trial comparator sourcing, packaging and labeling solutions, pre-approval and medicines access programs, and consulting. The company partner with life science companies of all sizes and has over 20 years of industry experience. Inceptua was founded in 1997, and Stefan Fraenkel has been the CEO since 2017. | Health Services |
- Stock Market
- Insiders
- Annika Kollén